2096:HKG
Simcere Pharmaceutical Group Ltd
11,02 HKD
arrow_upward
+1,75%(+0,19) 1D
16 ოქტ, 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2096...
Open
10,85 HKD
High
11,29 HKD
Low
10,85 HKD
Mkt. cap
28,30 მლრდ.
Avg. vol.
4,02 მლნ.
Volume
5,80 მლნ.
Dividend
1,88%
Quarterly dividend
0,05 HKD
Ex-dividend date
18 ივნ. 2025
P/E ratio
16,54
52-wk high
14,38 HKD
52-wk low
9,07 HKD
EPS
0,67 HKD
Shares outstanding
2,57 მლრდ.
No. of employees
7 ათ.
Open
10,85 HKD
High
11,29 HKD
Low
10,85 HKD
Mkt. cap
28,30 მლრდ.
Avg. vol.
4,02 მლნ.
Volume
5,80 მლნ.
Dividend
1,88%
Quarterly dividend
0,05 HKD
Ex-dividend date
18 ივნ. 2025
P/E ratio
16,54
52-wk high
14,38 HKD
52-wk low
9,07 HKD
EPS
0,67 HKD
Shares outstanding
2,57 მლრდ.
No. of employees
7 ათ.
News stories
From web sources and news partners
https://tech-insider.org/
·
12 წუთის წინ
Nasdaq Futures Rebound 0.7% as Earnings Week Looms
marketscreener.com
·
21 წუთის წინ
S&P 500 index slipped after the Stockholm exchange closed on Friday
The New York Times
·
49 წუთის წინ
On This Day, Oct. 19: In 1987, the stock market crashed.
Profile
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
About Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Employees7,06 ათ.
Founded1995
HeadquartersNanjing, Jiangsu, ჩინეთი
SectorPharmaceutical industry
Websitesimcere.com